Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending August 13, 2021

Overall drug TRx are flat

Vascepa
TRx 81,381; -2.4% (-2,008) w/w; -9.3% y/y
NRx 35,844; -2.8% (-1,050) w/w; -13.2% y/y
Ref 45,537; -2.1% (-959) w/w; -6.0% y/y

Lovaza (Generic & Brand)
TRx 62,518; -1.1% (-670) w/w; +0.4% y/y
NRx 30,051; +0.3% (+92) w/w; -2.0% y/y
Ref 32,467; -2.3% (-762) w/w; +2.6% y/y

Generic Vascepa
TRx 16,108; +6.5% (+985) w/w; As % of total V: 16.5%
NRx 9,056; +6.9% (+583) w/w; As % of total V: 20.2%
Ref 7,052; +6.0% (+402) w/w; As % of total V: 13.4%

Generic Vascepa by Manufacturer
Hikma TRx 12,063 (+546); Generic share 74.9%; Total V share 12.4%
Reddy TRx 4,045 (+439); Generic share 25.1%; Total V share 4.1%